US court rejects Natco Pharma partner’s complaint over Ibrutinib tablets | Tech Reddy
[ad_1] MT Newswires 2022 All news about NATCO PHARMA LIMITED Sale 2023 29 037 M 359 M 359 M Net income 2023 8 527 M 105 M 105 M Net debt 2023 – – – P/E ratio 2023 12.5x Harvest 2023 1.27% Capitalization 106 B 1 309 M 1 … Read more